Evaluation of Circulating Tumor DNA as a Biomarker for Chemoresistance in Colorectal Cancer
Background: Colorectal cancer (CRC) is a leading cause of cancer-related mortality globally. Resistance to chemotherapy, particularly to first-line regimens such as FOLFOX (5-fluorouracil, leucovorin, and oxaliplatin), remains a critical barrier to successful treatment. Methods: This prospective obs...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Medknow Publications
2025-12-01
|
| Seri Bilgileri: | Journal of Pharmacy and Bioallied Sciences |
| Konular: | |
| Online Erişim: | https://journals.lww.com/10.4103/jpbs.jpbs_1319_25 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|